The value of prostate-specific antigen in Asia

One of the most important diagnostic tools used to detect prostate cancer is prostate-specific antigen (PSA), yet increased PSA alone does not reflect the presence of prostate cancer. Other pathological prostatic conditions such as prostatitis and benign prostatic hyperplasia (BPH) may also increase...

Full description

Bibliographic Details
Main Authors: Chaidir Arif Mochtar, R. Siddhi Andika
Format: Article
Language:English
Published: SAGE Publishing 2010-04-01
Series:Therapeutic Advances in Urology
Online Access:https://doi.org/10.1177/1756287210370329
id doaj-58c3b170e0ea4c51b47e4b8f4f06a70f
record_format Article
spelling doaj-58c3b170e0ea4c51b47e4b8f4f06a70f2020-11-25T03:15:42ZengSAGE PublishingTherapeutic Advances in Urology1756-28722010-04-01210.1177/1756287210370329The value of prostate-specific antigen in AsiaChaidir Arif MochtarR. Siddhi AndikaOne of the most important diagnostic tools used to detect prostate cancer is prostate-specific antigen (PSA), yet increased PSA alone does not reflect the presence of prostate cancer. Other pathological prostatic conditions such as prostatitis and benign prostatic hyperplasia (BPH) may also increase the level of PSA. However, unlike in other prostate diseases, PSA has a key role in the diagnosis and management of prostate cancer. The incidence of prostate cancer varies from country to country, with the highest incidence being found in the Western world and the lowest in Asian countries. Owing to the low incidence of prostate cancer, there could be different views regarding the use of PSA in Asian countries, especially for the early detection/screening of prostate cancer. The purpose of this article is to review the use and value of PSA in the diagnosis of prostate diseases (especially prostate cancer) in Asian countries/populations. A literature search was performed in ‘MEDLINE’ (PubMed) and Google Scholar using main keywords such as ‘PSA’, ‘PSA usage’, ‘PSA sensitivity and specificity’, ‘Asia’, and various countries in Asia. Articles that provide population/community-based PSA data, together with the characteristics, distribution, and indications for PSA testing in the respective countries, were selected. Eleven papers were finally selected for inclusion in this review. Five studies found that PSA, by its 95th percentile value, have an age-referenced tendency in Asian males, similarly to the West. The predictive values of PSA in detecting prostate cancer are also quite similar to those in Western countries. With the exponential growth of the aging population in the world, especially in Asia, the incidence of prostate cancer will follow this upward trend. Therefore, PSA testing for screening or diagnostic purposes would increase with time in Asia.https://doi.org/10.1177/1756287210370329
collection DOAJ
language English
format Article
sources DOAJ
author Chaidir Arif Mochtar
R. Siddhi Andika
spellingShingle Chaidir Arif Mochtar
R. Siddhi Andika
The value of prostate-specific antigen in Asia
Therapeutic Advances in Urology
author_facet Chaidir Arif Mochtar
R. Siddhi Andika
author_sort Chaidir Arif Mochtar
title The value of prostate-specific antigen in Asia
title_short The value of prostate-specific antigen in Asia
title_full The value of prostate-specific antigen in Asia
title_fullStr The value of prostate-specific antigen in Asia
title_full_unstemmed The value of prostate-specific antigen in Asia
title_sort value of prostate-specific antigen in asia
publisher SAGE Publishing
series Therapeutic Advances in Urology
issn 1756-2872
publishDate 2010-04-01
description One of the most important diagnostic tools used to detect prostate cancer is prostate-specific antigen (PSA), yet increased PSA alone does not reflect the presence of prostate cancer. Other pathological prostatic conditions such as prostatitis and benign prostatic hyperplasia (BPH) may also increase the level of PSA. However, unlike in other prostate diseases, PSA has a key role in the diagnosis and management of prostate cancer. The incidence of prostate cancer varies from country to country, with the highest incidence being found in the Western world and the lowest in Asian countries. Owing to the low incidence of prostate cancer, there could be different views regarding the use of PSA in Asian countries, especially for the early detection/screening of prostate cancer. The purpose of this article is to review the use and value of PSA in the diagnosis of prostate diseases (especially prostate cancer) in Asian countries/populations. A literature search was performed in ‘MEDLINE’ (PubMed) and Google Scholar using main keywords such as ‘PSA’, ‘PSA usage’, ‘PSA sensitivity and specificity’, ‘Asia’, and various countries in Asia. Articles that provide population/community-based PSA data, together with the characteristics, distribution, and indications for PSA testing in the respective countries, were selected. Eleven papers were finally selected for inclusion in this review. Five studies found that PSA, by its 95th percentile value, have an age-referenced tendency in Asian males, similarly to the West. The predictive values of PSA in detecting prostate cancer are also quite similar to those in Western countries. With the exponential growth of the aging population in the world, especially in Asia, the incidence of prostate cancer will follow this upward trend. Therefore, PSA testing for screening or diagnostic purposes would increase with time in Asia.
url https://doi.org/10.1177/1756287210370329
work_keys_str_mv AT chaidirarifmochtar thevalueofprostatespecificantigeninasia
AT rsiddhiandika thevalueofprostatespecificantigeninasia
AT chaidirarifmochtar valueofprostatespecificantigeninasia
AT rsiddhiandika valueofprostatespecificantigeninasia
_version_ 1724638034477973504